Ocular Therapeutix, Inc.
Key Metrics
- Previous Close
- $5.94
- 52-Week Range
- $5.77 – $16.44
- Market Cap
- $1.29B
- P/E (TTM)
- —
- EPS (TTM)
- -1.44
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 2.92
- PEG Ratio
- —
- Return on Equity
- -93.48%
- Return on Assets
- -42.19%
- Gross Margin
- 0.00%
- Operating Margin
- -680.91%
- Profit Margin
- 0.00%
- Current Ratio
- 9.12
- Debt/Equity
- 0.18
- Total Debt
- $80.01M
- Free Cash Flow
- $-159.98M
- Revenue Growth
- -11.50%
- Earnings Growth
- —
- Enterprise Value
- $856.34M
Market Snapshot
About
Biopharmaceutical company developing innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform. The company focuses on sustained-release drug delivery systems that provide extended therapeutic benefits for patients with eye disorders.